A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors
- PMID: 17979310
- DOI: 10.1021/nl072209h
A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors
Abstract
Destruction of hypoxic regions within tumors, virtually inaccessible to cancer therapies, may well prevent malignant progression. The tumor's recruitment of monocytes into these regions may be exploited for nanoparticle-based delivery. Monocytes containing therapeutic nanoparticles could serve as "Trojan Horses" for nanoparticle transport into these tumor regions. Here we report the demonstration of several key steps toward this therapeutic strategy: phagocytosis of Au nanoshells, and photoinduced cell death of monocytes/macrophages as isolates and within tumor spheroids.
Similar articles
-
Nanoparticles for tumor targeted therapies and their pharmacokinetics.Curr Drug Metab. 2010 Feb;11(2):129-41. doi: 10.2174/138920010791110827. Curr Drug Metab. 2010. PMID: 20359289 Review.
-
Tumortropic monocyte-mediated delivery of echogenic polymer bubbles and therapeutic vesicles for chemotherapy of tumor hypoxia.Biomaterials. 2015 Dec;71:71-83. doi: 10.1016/j.biomaterials.2015.08.033. Epub 2015 Aug 19. Biomaterials. 2015. PMID: 26318818
-
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.Theranostics. 2020 Jun 12;10(17):7510-7526. doi: 10.7150/thno.44523. eCollection 2020. Theranostics. 2020. PMID: 32685002 Free PMC article.
-
Trojan horse monocyte-mediated delivery of conjugated polymer nanoparticles for improved photodynamic therapy of glioblastoma.Nanomedicine (Lond). 2020 Jul;15(17):1687-1707. doi: 10.2217/nnm-2020-0106. Epub 2020 Jul 21. Nanomedicine (Lond). 2020. PMID: 32689873
-
Selenium nanoparticles: potential in cancer gene and drug delivery.Nanomedicine (Lond). 2017 May;12(9):1075-1089. doi: 10.2217/nnm-2017-0024. Epub 2017 Apr 25. Nanomedicine (Lond). 2017. PMID: 28440710 Review.
Cited by
-
Bioactive nanotherapeutic trends to combat triple negative breast cancer.Bioact Mater. 2021 Mar 13;6(10):3269-3287. doi: 10.1016/j.bioactmat.2021.02.037. eCollection 2021 Oct. Bioact Mater. 2021. PMID: 33778204 Free PMC article. Review.
-
Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases.Theranostics. 2015 Jan 1;5(2):150-72. doi: 10.7150/thno.9476. eCollection 2015. Theranostics. 2015. PMID: 25553105 Free PMC article. Review.
-
Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells.Sci Transl Med. 2015 Jun 10;7(291):291ra94. doi: 10.1126/scitranslmed.aaa5447. Sci Transl Med. 2015. PMID: 26062846 Free PMC article.
-
Liposome-Tethered Gold Nanoparticles Triggered by Pulsed NIR Light for Rapid Liposome Contents Release and Endosome Escape.Pharmaceutics. 2022 Mar 25;14(4):701. doi: 10.3390/pharmaceutics14040701. Pharmaceutics. 2022. PMID: 35456535 Free PMC article. Review.
-
Platelets and their biomimetics for regenerative medicine and cancer therapies.J Mater Chem B. 2018 Dec 7;6(45):7354-7365. doi: 10.1039/C8TB02301H. Epub 2018 Oct 22. J Mater Chem B. 2018. PMID: 31372220 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources